公司概覽
業務類別 Biotechnology
業務概覽 Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
公司地址 Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7
電話號碼 +353 16347800
傳真號碼 +353 16347850
公司網頁 https://www.jazzpharmaceuticals.com
員工數量 2890
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Renee D. Gala President, Chief Executive Officer and Director 美元 1.00M 08/06/2026
Dr. Robert Iannone, M.D. Executive Vice President, Global Head of Research and Development and Chief Medical Officer 美元 793.08K 08/06/2026
Mr. Philip L. Johnson Executive Vice President and Chief Financial Officer 美元 741.35K 08/06/2026
Ms. Neena M. Patil Executive Vice President and Chief Legal Officer 美元 715.48K 08/06/2026
Ms. Patricia Carr Senior Vice President and Chief Accounting Officer -- 08/06/2026
Ms. Samantha Pearce Executive Vice President and Chief Commercial Officer 美元 695.67K 09/10/2026
Ms. Mary Elizabeth Henderson Senior Vice President, Technical Operations -- 08/06/2026
 
董事會成員
董事會 職務 更新日期
Mr. Bruce C. Cozadd Chairperson of the Board 08/06/2026
Mr. Patrick G. Enright, M.B.A. Independent Director 08/06/2026
Dr. Norbert G. Riedel,PhD Independent Director 08/06/2026
Dr. Ted W. Love, M.D. Independent Director 08/06/2026
Mr. Rick E. Winningham Lead Independent Director 08/06/2026
Ms. Heather Ann McSharry Independent Director 08/06/2026
Mr. Patrick Thomas Kennedy Independent Director 08/06/2026
Mr. Seamus C. Mulligan Independent Director 08/06/2026
Ms. Renee D. Gala President, Chief Executive Officer and Director 08/06/2026
Ms. Laura J. Hamill Independent Director 08/06/2026
Ms. Jennifer E. Cook Independent Director 08/06/2026
Dr. Mark D. Smith, M.D. Independent Director 08/06/2026
 
所屬ETF (更新日期: 14/11/2026 03:34)
代號 名稱 佔比% ▼ 持有日期
TPLCTimothy Plan US Large/Mid Cap Core ETF0.01%30/10/2026
SMMViShares MSCI USA Sm-Cp Min Vol Fctr ETF0.01%30/10/2026
AVMCAvantis U.S. Mid Cap Equity ETF0.01%30/10/2026
CFAVictoryShares US 500 Volatility Wtd ETF0.01%30/10/2026
AFMCFirst Trust Active Factor Mid Cap ETF0.01%29/10/2026
WSMLiShares MSCI World Small-Cap ETF0.01%30/10/2026
TPFCTimothy Plan Free Cash Flow ETF0.01%30/10/2026
DVLUFirst Trust Dorsey Wright Momt & Val ETF0.01%29/10/2026
SIXLETC 6 Meridian Low Beta Eq Strat ETF0.01%30/10/2026
CFOVictoryShares US 500 Enh Vol Wtd ETF0.01%30/10/2026
SMOXHorizon Small/Mid Cap Core Equity ETF0.01%30/10/2026
REVSColumbia Research Enhanced Value ETF0.01%31/10/2026
EQALInvesco Russell 1000 Equal Weight ETF0.005%30/10/2026
LVDSJPMorgan Fundamental Data Sci Lrg ValETF0.005%30/10/2026
FSCSFirst Trust SMID Capital Strength ETF0.004%29/10/2026
AVUQAvantis U.S. Quality ETF0.004%30/10/2026
GVLUGotham 1000 Value ETF0.004%30/10/2026
IYYiShares Dow Jones US ETF0.004%30/10/2026
BIBProShares Ultra Nasdaq Biotechnology0.004%30/10/2026
AVSUAvantis Responsible US Equity ETF0.004%30/10/2026
  1    2    3    4    5    6   7    8    9    10    11  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.